Amyloidosis (overview) E85.9/L99.0

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

This section has been translated automatically.

Virchow, 1854

This section has been translated automatically.

Heterogeneous group of diseases whose common feature is the extracellular deposition of a "waste protein", the amyloid, which cannot be utilized by the organism.

This section has been translated automatically.

A distinction is made between cutaneous and systemic amyloidoses. In systemic amyloidoses, a distinction is also made between primary and secondary (concomitant) amyloidoses, and between acquired and hereditary amyloidoses (see also amyloidosis, systemic):

This section has been translated automatically.

  1. Breathnach SM (1988) Amyloid and amyloidosis. J Am Acad Dermatol 18: 1-16
  2. Cohen AS, Jones LA (1993) Advances in Amyloidosis. Curr Opin Rheumatol 5: 62-76
  3. Dubrey S et al (2014) The transthyretin amyloidoses: advances in therapy. Postgraduate Med J doi: 10.1136/postgradmedj-2014-133224.
  4. Hung CC et al (2003) Unusual skin manifestation of cutaneous amyloidosis. Dermatology 207: 65-67
  5. Lubarsch O (1899) Hyaline and amyloid degeneration. Erg allg Path 4: 449-460
  6. Moon AO et al (2003) Nodular amyloidosis: review and long-term f-up of 16 cases. Arch Dermatol 139: 1157-1159
  7. Santos-Juanes J et al (2004) Nodular primary localized cutaneous amyloidosis. J Eur Acad Dermatol Venereol 18: 224-226
  8. Virchow R (1854) On the course of amyloid degeneration. Virch Arch 8: 364-368
  9. Woollons A et al (2001) Nodular localized primary cutaneous amyloidosis: a long-term follow-up study. Br J Dermatol 145: 105-109


Please ask your physician for a reliable diagnosis. This website is only meant as a reference.


Last updated on: 29.10.2020